Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quince Therapeutics, Inc. - Common Stock
(NQ:
QNCX
)
0.2000
-0.0255 (-11.31%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quince Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Discover the most active stocks in Friday's session.
↗
February 13, 2026
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
February 13, 2026
Via
Chartmill
Which stocks are moving on Thursday?
↗
February 12, 2026
Via
Chartmill
These stocks have an unusual volume in today's session
↗
February 12, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Thursday?
↗
February 12, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
February 12, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
February 12, 2026
Via
Chartmill
Micro-Caps Under $1: TOON, PRSO, RENX, QNCX, KIDZ Building Momentum
February 11, 2026
Via
AB Newswire
Topics
Economy
Intellectual Property
Curious about the most active stocks on Wednesday?
↗
February 11, 2026
Via
Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look.
↗
February 11, 2026
Via
Chartmill
Top stock movements in today's session.
↗
February 11, 2026
Via
Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
February 11, 2026
Via
Chartmill
These stocks are making the most noise in today's session.
↗
February 10, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
February 10, 2026
Via
Chartmill
Top movers in Tuesday's pre-market session
↗
February 10, 2026
Via
Chartmill
Why Is QNCX Stock Up 60% Pre-Market After A Near-Total Wipeout?
↗
February 10, 2026
The company announced that it has appointed LifeSci Capital as its exclusive financial advisor to support a restructuring effort and review strategic alternatives.
Via
Stocktwits
Why Is Quince Therapeutics Stock Soaring Tuesday?
↗
February 10, 2026
Quince Therapeutics (NASDAQ: QNCX) engages LifeSci as financial advisor to explore strategic alternatives. Stock jumps.
Via
Benzinga
Monday's after hours session: top gainers and losers
↗
February 09, 2026
Via
Chartmill
Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives
February 09, 2026
From
Quince Therapeutics, Inc.
Via
Business Wire
The trading volume of these stocks is deviating from the norm in today's session.
↗
February 02, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
January 30, 2026
Via
Chartmill
Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session.
↗
January 30, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
January 30, 2026
Via
Chartmill
Why Did QNCX Stock Plummet Over 90% Today?
↗
January 29, 2026
The company announced that it has decided to cease clinical development of its lead asset dexamethasone sodium phosphate encapsulated in autologous erythrocytes (eDSP).
Via
Stocktwits
Topics
Bankruptcy
Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia
January 29, 2026
From
Quince Therapeutics, Inc.
Via
Business Wire
Quince Therapeutics Presents Safety Data from Long-Term eDSP Treatment in Children with Ataxia-Telangiectasia at British Paediatric Neurology Association Annual Meeting
January 28, 2026
From
Quince Therapeutics, Inc.
Via
Business Wire
Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia
December 15, 2025
From
Quince Therapeutics, Inc.
Via
Business Wire
Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders
December 10, 2025
From
Quince Therapeutics, Inc.
Via
Business Wire
Wednesday's session: top gainers and losers
↗
November 26, 2025
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Which stocks are moving on Wednesday?
↗
November 26, 2025
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.